Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: A randomized comparison

American Heart Journal

Volumn 148, Issue 3, 2004, Pages 467-474

  Ijsselmuiden, Alexander J J ^a,e   Ezechiels, JanPaul ^a   Westendorp, Iris C D ^a   Tijssen, Jan G P ^b   Kiemeneij, Ferdinand ^a   Slagboom, Ton ^a   Van Der Wieken, Ron ^a   Tangelder, GeertJan ^c   Serruys, Patrick W ^d   Laarman, GertJan ^a  

^a Amsterdam Dept Interventional C   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SAFETY; STENOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIRECT SERVICE COSTS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 4644302961     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.03.026     Document Type: Article

References (13)

1. King S.B. III. The development of interventional cardiology. J Am Coll Cardiol. 31:(4 Suppl B):1998;64B-88B
2. Cowley M.J., Vandermael M., Topol E.J., et al. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group. J Am Coll Cardiol. 22:1993;1289-1297
3. Faxon D.P., Ghalilli K., Jacobs A.K., et al. The degree of revascularization and outcome after multivessel coronary angioplasty. Am Heart J. 123:1992;854-859
4. Reeder G.S., Holmes D.R. Jr, Detre K., et al. Degree of revascularization in patients with multivessel coronary disease a report from the National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 77:1988;638-644
5. Cavallini C., Risica G., Olivari Z., et al. Clinical and angiographic follow-up after coronary angioplasty in patients with two-vessel disease influence of completeness and adequacy of revascularization on long-term outcome. Am Heart J. 127:1994;1504-1509
6. Kussmaul W.G. III, Krol J., Laskey W.K., et al. One-year follow-up results of "culprit" versus multivessel coronary angioplasty trial. Am J Cardiol. 71:1993;1431-1433
7. Vandormael M.G., Chaitman B.R., Ischinger T., et al. Immediate and short-term benefit of multilesion coronary angioplasty influence of degree of revascularization. J Am Coll Cardiol. 6:1985;983-991
8. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:2002;1773-1780
9. TIMI Study Group. Thrombolysis in Myocardial Infarction (TIMI) trial phase I findings. N Engl J Med. 312:1985;932-936
10. Afifi A.A., Clark V. Computer-aided multivariate analysis. 3rd edition:1996;Chapman Hall, Texts in Statistical Science Series, London, England
11. Samson M., Meester H., DeFeyter P.J., et al. Successful multiple segment coronary angioplasty effect of completeness of revascularization in single-vessel multilesions and multivessels. Am Heart J. 120:1990;1-12
12. Bourassa M.G., Kip K.E., Jacobs A.K., et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 33:1999;1627-1636
13. Van den Brand M.J.B.M., Rensing B.J.W.M., Morel M.M., et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 39:2002;559-564